The Economic Times
English EditionEnglish Editionहिन्दी
| E-Paper
Search
+

Death of Bhopal volunteer cast a shadow over Bharat Biotech's Covid vaccine

Death of Bhopal volunteer cast a shadow over Bharat Biotech's Covid vaccine
Death of Bhopal volunteer cast a shadow over Bharat Biotech's Covid vaccine
Trials in Bhopal being conducted in gross violation of laws, say health activist.

Synopsis

Bharat Biotech in a statement issued on Saturday had said that the death of the 42-year-old man in Bhopal who participated in the trial was not related to the vaccine.

NEW DELHI: Jitendra Narwariya was administered Bharat Biotech’s vaccine candidate Covaxin on December 10 at People’s College of Medical Sciences & Research in Bhopal as part of the company’s phase-3 trials. A few days later, he had fever, weakness and lack of appetite. He has not gone back to work since December 14 because of his deteriorated health conditions, his mother Gulab Bai said on Sunday. Like several others, Narwariya had heard
Share This Article
  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • COMMENT

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads
  • Comment & Engage with ET Prime community
  • Exclusive invites to Virtual Events with Industry Leaders
  • A trusted team of Journalists & Analysts who can best filter signal from noise
The Economic Times